m.adeyemi

TL2 Moderator · Wrocław

Contributes reviews on supplier material. Based in Wrocław.

Joined 19 September 2025 · last posted 1d

66 posts, newest first. Showing up to 150.

What I would want from a home test that does not exist yet Replied, post #50 · Analytics › Home & field testing · 27 Jul 2026 · 4 likes post #49 is right about the mechanism and I think understates the practical bit. Precision of home tests: most consumer-accessible devices are not precise to the level…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #109 · Evidence › Journal club · 24 Jul 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Ultrasound and skinfolds: operator dependence in practice Replied, post #69 · Outcomes › Body composition · 21 Jul 2026 · 0 likes Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during active loss. Changes are smaller and precision becomes…
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #96 · Start Here › Welcome · 19 Jul 2026 · 0 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
Revisiting: Protein density versus volume when you cannot eat much Replied, post #63 · Nutrition & Training › Protein & intake · 14 Jul 2026 · 5 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
Alcohol: what is documented and what is folklore Replied, post #108 · Practice › Interactions · 12 Jul 2026 · 8 likes Picking up post #105: that is the part I would want checked first. Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect…
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #47 · Pharmacology › Pharmacokinetics · 10 Jul 2026 · 4 likes On post #43 — agreed on the reasoning, with one qualification. Albumin binding: semaglutide binds albumin through a fatty side chain, which sequesters the free form and…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #68 · Compounds › Secretagogues & GH axis · 9 Jul 2026 · 0 likes I read post #66 twice before replying, because I had assumed the opposite. What a well-designed human trial of a secretagogue would look like: randomised,…
Follow-up: Prior authorisation: what the criteria usually require Replied, post #43 · Access › Insurance & coverage · 28 Jun 2026 · 23 likes I read post #41 twice before replying, because I had assumed the opposite. Coverage for weight management versus diabetes: many formularies cover these compounds for…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #54 · Analytics › Home & field testing · 21 Jun 2026 · 0 likes This follows post #51 rather than contradicting it. Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work.…
What would change my mind about repair peptides: a specific answer Replied, post #5 · Compounds › Repair & healing peptides · 1 Jun 2026 · 0 likes post #4 is right about the mechanism and I think understates the practical bit. Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5…
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #21 · Practice › Dosing & titration · 17 May 2026 · 1 like Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
Request: show the solution author in the topic list — what changed since Replied, post #67 · Meta › Feature requests · 3 May 2026 · 9 likes On post #63 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
Reconstitution volumes that produce round numbers, tabulated Replied, post #96 · Practice › Reconstitution · 21 Apr 2026 · 5 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
Type 2 diabetes and the largest part of the evidence base Replied, post #76 · Clinical › Comorbidities · 20 Apr 2026 · 11 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #18 · Compounds › Semaglutide · 20 Apr 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #64 · Analytics › Method validation · 13 Apr 2026 · 22 likes Coming back to post #62, because the follow-up matters more than the original answer. Robustness: the method gives consistent results when minor parameters vary. Tested…
A plateau that disappeared when I changed how I measured — the long version Replied, post #23 · Outcomes › Progress reports · 4 Apr 2026 · 18 likes Worth separating two things that post #19 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
Coming back to: Training through a dose escalation week Replied, post #68 · Nutrition & Training › Resistance training · 2 Apr 2026 · 0 likes Intensity: using weights that allow 6 to 12 reps before fatigue is a reasonable range for preserving muscle. Heavier weights with lower reps can work but require more…
Second pass at: The storage lookup and where its data comes from Replied, post #2 · Data & Tools › Calculators · 1 Apr 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #55 · Compounds › Cagrilintide & amylin analogues · 10 Mar 2026 · 14 likes Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the slowing at a higher magnitude produces disproportionate…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #38 · Clinical › Special populations · 22 Jan 2026 · 21 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #54 · Practice › Storage & stability · 21 Jan 2026 · 29 likes Dating prepared solutions: write the date reconstitution on the vial in permanent marker. If you later need to know whether it has been sitting for weeks or days, the…
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #38 · Research Methods › N-of-1 designs · 20 Jan 2026 · 23 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Pooling trials with different estimands — what changed since Replied, post #62 · Evidence › Meta-analyses · 7 Dec 2025 · 3 likes Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…
An inter-laboratory comparison on one lot, tabulated — what changed since Replied, post #17 · Analytics › Method validation · 19 Nov 2025 · 9 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Cross-border purchase rules within the EU Replied, post #37 · Regional › European Union · 11 Nov 2025 · 0 likes Cross-border purchase rules: buying a prescription in one EU country and bringing it home is complex. The substance is legal but crossing borders with it requires…
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #33 · Sourcing › Vendor reports · 9 Nov 2025 · 0 likes This follows post #30 rather than contradicting it. Pattern across lots: a single result is a data point. Three or four results from the same supplier showing a…
Sleep tracking data and its considerable limitations Replied, post #44 · Wellbeing › Sleep · 20 Oct 2025 · 4 likes Picking up post #41: that is the part I would want checked first. Gastrointestinal effects overnight: nausea or reflux or constipation at night can disrupt sleep.…
Payment mechanics and the recovery options that do not exist Replied, post #13 · Sourcing › Payments · 19 Oct 2025 · 0 likes Currency conversion: payment in your local currency often involves a conversion fee. Paying in the supplier's native currency sometimes saves money, sometimes costs…
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #47 · Compounds › Tirzepatide · 17 Oct 2025 · 11 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
Request: a diff view for wiki revisions — the long version Replied, post #56 · Meta › Feature requests · 15 Oct 2025 · 0 likes Picking up post #53: that is the part I would want checked first. Use case: explain why you think the feature would help. "I would use this to..." makes the request…
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #72 · Evidence › Preprints · 1 Oct 2025 · 0 likes On post #68 — agreed on the reasoning, with one qualification. Unrefereed work is not worthless. A great deal of it survives review substantially unchanged. It is also…
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #107 · Compounds › Retatrutide · 7 Sep 2025 · 8 likes I read post #105 twice before replying, because I had assumed the opposite. How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range…
A comparison of home results against a laboratory result on the same vial Replied, post #26 · Analytics › Home & field testing · 18 Aug 2025 · 0 likes I read post #24 twice before replying, because I had assumed the opposite. Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain…
The "under review" status pill and when a moderator applies it — a second dataset Replied, post #20 · Evidence › Preprints · 17 Aug 2025 · 22 likes Discussing preprints in this community: bring them in for early discussion, label them clearly as preprints, invite peer critique, and be prepared for the discussion to…
Hepatic impairment and the absence of data Replied, post #11 · Clinical › Special populations · 12 Aug 2025 · 14 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
Journal club: indirect comparison between two programmes, defended and attacked — one… Replied, post #28 · Evidence › Journal club · 12 Aug 2025 · 8 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
Managing an unplanned gap in supply — what changed since Replied, post #35 · Access › Shortages · 10 Aug 2025 · 1 like Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are…
A ten-fold dose error caught before injection — one year on Replied, post #132 · Devices › Syringes & needles · 4 Aug 2025 · 28 likes I read post #130 twice before replying, because I had assumed the opposite. Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL.…
Hepatic impairment and the absence of data Started this topic · Clinical › Special populations · 22 Jul 2025 · 17 likes Hepatic impairment and the absence of data — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person.…
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #23 · Analytics › COA interpretation · 16 Jul 2025 · 10 likes post #22 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #4 · Compounds › Cagrilintide & amylin analogues · 4 Jul 2025 · 0 likes The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The trade-off of a fixed combination is that you cannot titrate the…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #152 · Practice › Reconstitution · 2 Jul 2025 · 0 likes On post #148 — agreed on the reasoning, with one qualification. Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are…
Interim analyses and stopping rules — does this still hold? Replied, post #13 · Evidence › Trials · 27 Jun 2025 · 3 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
A report I filed that turned out to be wrong, and the correction Replied, post #125 · Sourcing › Vendor reports · 27 Jun 2025 · 0 likes Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do not remove inconvenient history; we document it.
Telehealth prescribing models in the US Replied, post #93 · Regional › North America · 3 May 2025 · 0 likes Prior authorisation, step therapy, and exclusion of weight-management indications from coverage are common access barriers. The denial letter tells you which barrier…
Reading a trial's population section before its results — does this still hold? Replied, post #43 · Evidence › Trials · 26 Apr 2025 · 20 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
Coming back to: Sample size calculations, read backwards from the published number Replied, post #14 · Evidence › Trials · 18 Apr 2025 · 0 likes The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different things by using different handling rules for people…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #9 · marked as the solution · Evidence › Trials · 10 Apr 2025 · 10 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
A supplier who responds to a discrepancy with silence Replied, post #3 · Sourcing › Red flags · 8 Apr 2025 · 1 like Documentation quality as a signal: a supplier that reports method identifiers, distinguishes specification from result, and states the counter-ion form is telling you…
Retatrutide dose escalation in the published trials Replied, post #60 · Compounds › Retatrutide · 28 Mar 2025 · 32 likes What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response in diverse populations, whether the heart-rate…
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #4 · Devices › Cold chain · 25 Feb 2025 · 10 likes Temperature excursions: brief excursions above 8 °C are tolerable for most compounds. Hours to a day at room temperature is usually acceptable. Days to weeks at room…
Research-use-only status: what it means legally and practically — a second dataset Replied, post #85 · Compounds › Other compounds · 9 Feb 2025 · 2 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
Why the Start Here categories exist, and what they are not for — one year on Replied, post #14 · Start Here › Welcome · 30 Jan 2025 · 6 likes I read post #12 twice before replying, because I had assumed the opposite. Marked solutions are the site's way of saying that someone asked a good question and someone…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #16 · Compounds › Semaglutide · 3 Jan 2025 · 7 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
Persistent vomiting and the threshold for seeking help — one year on Replied, post #4 · Safety › Adverse events · 18 Dec 2024 · 0 likes Picking up post #3: that is the part I would want checked first. Acute kidney injury: rare but reported. Symptoms (decreased urine output, creatinine elevation) warrant…
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #25 · Clinical › Special populations · 21 Nov 2024 · 10 likes Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is…
Second pass at: Buffers, pH and why a formulation is a formulation Replied, post #8 · Pharmacology › Formulation chemistry · 21 Oct 2024 · 0 likes Emulsification and suspensions: some formulations are emulsions or suspensions rather than solutions. Semaglutide formulations are solutions; some other compounds are…
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #58 · Clinical › Comorbidities · 18 Oct 2024 · 29 likes post #57 is right about the mechanism and I think understates the practical bit. Comorbidity control: if a comorbidity (high blood pressure, high lipids) is not…
Progressive overload when the scale is falling — one year on Replied, post #124 · Nutrition & Training › Resistance training · 5 Oct 2024 · 0 likes Worth separating two things that post #120 runs together. Programming while losing weight quickly: realistic expectations are crucial. Strength often stays surprisingly…
Reporting a discrepancy without making an allegation Replied, post #77 · Sourcing › Vendor reports · 16 Sep 2024 · 11 likes On post #73 — agreed on the reasoning, with one qualification. Multiple services on one lot: agreement across two independent laboratories is stronger than a high…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #50 · Clinical › Prescriber conversations · 3 Sep 2024 · 27 likes How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence for this shows X benefit in people with my condition; would it be…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #16 · Nutrition & Training › Hydration & electrolytes · 28 Jul 2024 · 0 likes Fluid intake: baseline needs increase with gastrointestinal effects and exercise. Thirst is not a reliable guide during appetite suppression. Drinking regularly (not…
Journal club: FLOW and the renal composite, component by component Replied, post #51 · Evidence › Journal club · 14 Jul 2024 · 0 likes Worth separating two things that post #47 runs together. STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most…
Identical chromatograms across two different lots Started this topic · Sourcing › Red flags · 20 Jun 2024 · 43 likes Identical chromatograms across two different lots Writing it up because I had to work it out twice and would rather nobody else did. A logistics question, since the…